Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer
|
Re: Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer
This is a great post. I received 9 week Herceptin and Taxotere and was Stage IIIB four years ago. So far, there is no evidence of disease and I'm in good condition. No doubt, this was the best treatment to me.
|
Re: Nine versus 52 weeks of adjuvant trastuzumab in early breast cancer
Ursula,
I am so happy to hear you are doing well. Thanks for sharing your experience; I know many patients grow anxious when they have to stop Herceptin before their one year is up due to heart problems. Your post is a boost to all of them. Regards, Hopeful |
All times are GMT -7. The time now is 09:37 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021